Doug Schantz
About Doug Schantz
Doug Schantz serves as the Senior Vice President of Clinical Operations at Asklepios BioPharmaceutical, Inc., where he has worked since 2022. With over 30 years of experience in drug development, he has held significant roles at Pfizer, AstraZeneca, and Eli Lilly, focusing on clinical trial quality and delivery.
Work at Asklepios BioPharmaceutical
Doug Schantz serves as the Senior Vice President of Clinical Operations at Asklepios BioPharmaceutical, Inc. (AskBio) since 2022. In this role, he is responsible for ensuring the quality and delivery of clinical trials across AskBio's gene therapy development portfolio. He leads a multi-disciplinary clinical operations organization that includes clinical trial management, data management, monitoring, medical writing, and biostatistics. His position is based in Saline, Michigan, and allows for remote work.
Previous Experience at Pfizer
Before joining AskBio, Doug Schantz worked at Pfizer as the Executive Director of Clinical Operations from 1998 to 2015. During his 17 years at Pfizer, he gained extensive experience in drug development and clinical operations, contributing to various projects and initiatives within the organization.
Experience at AstraZeneca
Doug Schantz held the position of Executive Director at AstraZeneca from 2015 to 2020. His five years at AstraZeneca further solidified his expertise in clinical operations and drug development, enhancing his leadership skills in managing clinical trials and related processes.
Education and Expertise
Doug Schantz earned a Bachelor of Arts degree in Public Administration/Healthcare Management from Kean University, where he studied from 1986 to 1990. With over 30 years of experience in drug development, he has held various roles in clinical project management, study management, data management, regulatory submission coordination, and international clinical trials.
Networking Interests in Pharmaceuticals
Doug Schantz is interested in networking opportunities within the pharmaceuticals and contract research organizations. His strong background in clinical operations, team building, and leadership positions him as a valuable contact in the industry.